The impact of an angiosome-targeted revascularization on healing rate, limb salvage and survival in critical limb threatening ischemia.


Journal

Acta chirurgica Belgica
ISSN: 0001-5458
Titre abrégé: Acta Chir Belg
Pays: England
ID NLM: 0370571

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 3 6 2021
medline: 29 3 2022
entrez: 2 6 2021
Statut: ppublish

Résumé

According to the angiosome concept ulcer healing and limb salvage should be superior if direct arterial flow to the source vessel of an affected angiosome is established compared to indirect flow where the angiosome is perfused by means of collaterals. The objective of this study was to evaluate the impact of direct versus indirect revascularization (DR/IR) in endovascular versus bypass surgery on ulcer healing, limb salvage and mortality. A retrospective analysis of both endovascular and bypass distal (below the knee) lower limb revascularizations for chronic limb-threatening ischemia (CLTI) between 1993 and 2014 was performed. The study population consisted of 126 endovascular and 198 bypass procedures. DR and IR were achieved in 57.4% and 42.6% limbs respectively. DR was not superior to IR regarding all three major endpoints when endovascular and bypass procedures were analyzed separately. Endovascular and bypass procedures resulted in comparable healing rates. All patients who did not achieve wound healing (HR 7.49; 95% CI 4.25-13.20, This retrospective study with comparable results for DR and IR did not support the angiosome concept. Achieving wound healing remains critical in patients with CLTI to reduce major amputation rates. Overall the implications of the angiosome concept seem to be limited due to its feasibility in patients with CLTI.

Identifiants

pubmed: 34076565
doi: 10.1080/00015458.2021.1881337
pii: 10.1080/00015458.2021.1881337
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-115

Auteurs

Alexander Croo (A)

Department of Thoracic and Vascular Surgery, Ghent University Hospital, Ghent, Belgium.

Timothy Versyck (T)

Department of Thoracic and Vascular Surgery, Ghent University Hospital, Ghent, Belgium.

Alec Duinslaeger (A)

Department of Thoracic and Vascular Surgery, Ghent University Hospital, Ghent, Belgium.

Charlotte Harth (C)

Department of Thoracic and Vascular Surgery, Ghent University Hospital, Ghent, Belgium.

Frank Vermassen (F)

Department of Thoracic and Vascular Surgery, Ghent University Hospital, Ghent, Belgium.

Caren Randon (C)

Department of Thoracic and Vascular Surgery, Ghent University Hospital, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH